期刊文献+

非瓣膜性心房颤动患者行左心耳封堵术的初步结果 被引量:6

The Preliminary Results of Left Atrial Appendage Occlusion in Patients With Non-valvular Atrial Fibrillation
下载PDF
导出
摘要 目的:探讨非瓣膜性心房颤动患者行左心耳封堵术的可行性及围术期、术后近期的安全性。方法:对17例非瓣膜性心房颤动患者入院当天及术后随访时常规行经食管超声心动图(TEE)检查;并于入院后进行CAHDS_2评分测定,对符合入选标准的患者进行左心耳封堵手术治疗。观察患者围术期及术后随访时封堵效果及并发症发生情况。结果:17例患者均成功完成手术,无严重并发症发生。术后8例TEE提示存在少量残余分流,围术期有2例术后存在穿刺点瘀斑,3例新发少量心包积液。平均随访45天时仅3例患者存在少量残余分流,未见左心房血栓形成及心包积液。结论:非瓣膜性心房颤动患者行左心耳封堵术成功率高,围术期及近期随访安全性良好。 Objective: To explore the feasibility with the safety at peri-operative and early post-operative periods for left atrial appendage occlusion in patients with non-valvular atrial fibrillation (AF). Methods: A total of 17 non-valvular AF patients with transesophageal echocardiography (TEE) and CAHDS2 evaluation who received left atrial appendage occlusion in our hospital were summarized. The effect and complications during peri- operative and 1 month post-operative periods were analyzed. Results: All 17 patients had successful operation without severe complications. There were 8 patients having small amount residual shunt by TEE examination, 2 having ecchymosis near the puncture point at peri-operative period and 3 having small amount of hydropericardium by peri-cardio ultrasound examination. At the average of 45 days follow-up study, only 3 patients had small amount residual shunt, no left atrium thrombus and hydropericardium were observed. Conclusion: Left atrial appendage occlusion has the high success rate, it is safe during peri-operative and early post- operative periods in non-valvular AF patients.
出处 《中国循环杂志》 CSCD 北大核心 2015年第10期989-992,共4页 Chinese Circulation Journal
关键词 心房颤动 左心耳 血栓 Atrial fibrillation Left atrial appendage Thrombus
  • 相关文献

参考文献14

  • 1Kannel WB, Abbott RD, Savage DD, et al. Epidemiologie features of chronic atrial flrillation: the Framingham study. N Engi J Med, 1982, 306: 1018-1022.
  • 2Wolf PA, Abbott RD, Kannel WB. Atrial fbrillation as an independent risk factor for stroke: the Framingham study. Stroke, 1991, 22: 983- 988.
  • 3Benjamin E J, Wolf PA, D'Agostino RB, et al. Impact of atrial fbrillation on the risk of death: the Framingham Heart Study. Circulation, 1998, 98: 946-952.
  • 4胡大一,杨进刚.心房颤动的现代观点 (1)我国心房颤动流行概况和危害[J].中国循环杂志,2004,19(5):323-324. 被引量:40
  • 5Madden J. Resection of the left auricular appendix. J Am Med Assoc 1948. 140: 769-772.
  • 6Bailey C, Olsen A, Keown K, et al. Commissurotomy for mitral stenosis technique for prevention of cerebral complications. J Am Med Assoe, 1952, 149: 1085-1091.
  • 7Belcher JR, Somerville W. Systemic: embolism and left atriatricular thrombosis in relation to mitral stenosis. Br Med, 1955, 2: 1000-1003.
  • 8Meier B, Palacica I, Windeckev S, et al. Trancatheter left atrial appendage occlusion with Amplatner devicea to obviate antiongulation in pelienin with aerial fibrillation. Catheter Cardiovasc Inter, 2003, 60: 417-422.
  • 9Omran H, Hardung D, Schmidt H, et al. Meehanical occluaion of the left atrial appendage. J Cardiovanc Elevtrophymiol, 2003, 14: $56-59.
  • 10胡大,姚焰.心房颤动(3)心房颤动导管消融的远期随访.中围循环杂志.2014.1:6-8.

二级参考文献25

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1397
  • 2Dentali F, Riva N, Crowther M, et al. Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta- analysis of the literature. Circulation, 2012, 126: 2381-2391.
  • 3O' Dell KM, Igawa D, Hsin J. New oral anticoagulants for atrial fibrillation: a review of clinical trials. Clinical Therapeutics, 2012, 34: 894-901.
  • 4San TR, Chan MYY, Siong TW, et al. Stroke prevention in atrial fibrillation: understanding the new oral anticoagulants Dabigatran,Rivaroxaban, and Apixaban. Thrombosis,2012, 2012:108983.
  • 5Dogliotti A, Paolasso E, Giugliano RP. Novel oral anticoagulants in atrial fibrillation: a recta-analysis of large, randomized, controlled trials vs warfarin. Clin Cardiol, 2013, 36: 61-67.
  • 6Miller CS, Grandi SM, Shimony A, et al. Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation. Am J Cardiol, 2012, 110: 453-460.
  • 7Anderson JL, Halperin JL, Albert NM,et al. Management of Patients With Atrial Fibrillation (Compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS Recommendations) : A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 2013, 127:1916-1926.
  • 8John Carom A, Lip GYH, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation:an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Europace, 2012, 14:1385-1413.
  • 9Manolis AS, Manolis TA, Melita H. Novel oral anticoagulants for stroke prophylaxis in non-valvular atrial fibrillation: agent selection and patient monitoring. Hospital Chronicles, 2013, 8:151-163.
  • 10Skanes AC, Healey JS, Cairns JA, et al. Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control. Canadian Journal of Cardiology, 2012, 28:125-136.

共引文献50

同被引文献35

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部